[1]
M. J. Muhammad, A. I. Muhammed, and H. M. Jassim, “Formulation of Neomycin Sulphate 0.35 %(w/v) & Hydrocortisone 0.5% Otic Drop”, IJOIR, vol. 9, no. 1, pp. 115–119, Jun. 2022.